Tags: Drug.
Bevacizumab (pronounced /bev-a-Sizz-you-mab/ trade name Avastin Genentech/Roche) is an angiogenesis inhibitor as a drug that slows the growth of new blood vessels. It is licensed to treat various cancers including colorectal lung breast (outside the USA) glioblastoma (USA only) kidney and ovarian.Bevacizumab is a humanized monoclonal antibody that produces angiogenesis inhibition by inhibiting vascular endothelial growth factor A (VEGF-A).